Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine

International Journal of Cancer

Volumn 73, Issue 5, 1997, Pages 763-768

  Courage, Carol ^a   Bradder, Stephen M ^a   Jones, Tonya ^a   Schultze Mosgau, Marcus H ^a   Gescher, Andreas ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4'-N-BENZOYLSTAUROSPORINE; 7 HYDROXYSTAUROSPORINE; 7-HYDROXYSTAUROSPORINE; ABC TRANSPORTER; ALKALOID; DRUG DERIVATIVE; ENZYME INHIBITOR; GLYCOPROTEIN P; INDOLE DERIVATIVE; MIDOSTAURIN; MULTIDRUG RESISTANCE PROTEIN; PROTEIN KINASE C; RO 31-8220; STAUROSPORINE;

ADENOCARCINOMA; ARTICLE; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; HUMAN; LUNG TUMOR; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY;

ADENOCARCINOMA; ALKALOIDS; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIVISION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; INDOLES; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROTEIN KINASE C; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0031588369     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971127)73:5<763::AID-IJC25>3.0.CO;2-5     Document Type: Article

References (37)

1. AKINAGA, S., GOMI, K., MOTIMOTO, M., TAMAOKI, T. and OKABE, M., Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res., 51, 4888-4892 (1991).
2. BAIER, G., BAIER-BITTERLICH, G., MELLER, N., COGGESHALL, K.M., GIAMPA, L., TELFORD, D., ISAKOV, N. and ALTMAN, A., Expression and biochemical characterization of human protein kinase C-theta. Europ. J. Biochem., 225, 195-203 (1994).
3. BELTMAN, J., MCCORMICK, F. and COOK, S.J., The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-jun expression, and activates jun N-terminal kinase. J. biol. Chem., 271, 27018-27024 (1996).
4. BLOBE, G.C., SACHS, C.W., KHAN, W.A., FABBRO, D., STABEL, S., WETSEL, W.C., OBEID, L.M., FINE, R.L. and HANNUN, Y.A., Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC-α. J. biol. Chem., 268, 658-664 (1993).
5. BORNER, C. and FABBRO, D., PKC and cellular transformation. In: D.S. Lester and R. Epand (eds.), Protein kinase C - current concepts and future perspectives, pp. 297-354, Ellis Horwood, Chichester (1992).
6. BORNER, C., UEFFING, M., JAKEN, S., PARKER, P.J. and WEINSTEIN, I.B., Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. J. biol. Chem., 270, 78-86 (1995).
7. BRADFORD, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
8. BÜCHLER, M., KÖNIG, J., BROM, M., KARTENBECK, J., SPRING, H., HORIES, T. and KEPPLER, D., cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. biol. Chem., 271, 15091-15098 (1996).
9. BUDWORTH, J., DAVIES, R., MALKHANDI, J., GANT, T.W., FEFFY, D.R. and GESCHER, A., Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells. Brit. J. Cancer, 73, 1063-1068 (1996).
10. CACACE, A.M., GUADAGNO, S.N., KRAUSS, R.S., FABBRO, D. and WEINSTEIN, I.B., The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene, 8, 2095-2104 (1993).
11. CHAUDHARY, P.M. and RONINSON, I.B., Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. nat. Cancer Inst., 85, 632-639 (1993).
12. COURAGE, C., BUDWORTH, J. and GESCHER, A., Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Brit. J. Cancer, 71, 697-704 (1995).
13. DALE, I.L., BRADSHAW, T.D., GESCHER, A. and PETTIT, G.R., Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Cancer Res., 49, 3242-3245 (1989).
14. DAVIS, P.D., ELLIOTT, L., HAEEIS, W., HURST, S.A., KEECH, E., KUMAR, H., LAWTON, G., NIXON, J.S. and WILKINSON, S.E., Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J. med. Chem., 35, 994-1001 (1992).
15. DEAN, N., MCKAY, R., MIRGLIA, L., HOWARD, R., COOPER, S., GIDDINGS, J., NICKLIN, P., MEISTER, L., ZIEL, R., GEIGER, T., MÜLLER, M. and FABBRO, D., Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res., 56, 3499-3507 (1996).
16. DLUGOSZ, A.A. and YUSPA, S.H., Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro. Cancer Res., 51, 4677-4684 (1991).
17. GEKELER, V., BOER, R., ISE, W., SANDERS, K.H., SCHÄCHTELE, C. and BECK, J., The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem. biophys. Res. Comm., 206, 119-126 (1995).
18. GESCHER, A. and REED, D.J., Characterization of the growth inhibition by tumour promoting phorbol esters and of their receptor binding in A549 human lung carcinoma cells. Cancer Res., 45, 4325-4329 (1985).
19. GOLLAPUDI, S., PATEL, K., JAIN, V. and GUPTA, S., Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport. Cancer Lett., 62, 69-75 (1992).
20. 1 between the cyclin D and cyclin E restriction points. Cancer Res., 54, 3136-3139 (1994).
21. GREIF, H., BEN-CHAIM, J., SHIMON, T., BECHOR, E., ELDAR, H. and LIVNEH, E., The protein kinase C related PKC-L (η) gene product is localized in the cell nucleus. Mol. cell. Biochem., 12, 1304-1311 (1992).
22. JAKEN, S., Protein kinase C isozymes and substrates. Curr. Opin. Cell. Biol., 8, 168-173 (1996).
23. JONES, T., COURAGE, C. HUBBARD, A. and GESCHER, A., Cellular relocalisation of protein kinase C-theta caused by staurosporine and some of its analogues. Biochem. Pharmacol. 53, 1413-1418 (1997).
24. KAWAKAMI, K., FUTAMI, H., TAKAHARA, J. and YAMAGUCHI, K., UCN-01, 7-hydroxystaurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem. biophys. Res. Comm., 219, 778-783 (1996).
25. KILEY, S.C., PARKER, P.J., FABBRO, D. and JAKEN, S., Selective redistribution of protein kinase C isoenzyme by thapsigargin and staurosporine. Carcinogenesis, 13, 1997-2001 (1992).
26. MEYER, T., REGENASS, U., FABBRO, D., ALTERI, E., RÖSEL, J., MÜLLER, M., CARAVATTI, G. and MATTER, A., A derivative of staurosporine (CGP 41251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vitro antitumour activity. Int. J. Cancer, 43, 851-856 (1989).
27. NISHIZUKA, Y., Intracellular signaling by hydrolysis of phospholipids and activation of PKC. Science, 258, 607-614 (1992).
28. POSADA, J., MCKEEGAN, E., WORTHINGTON, K., MORIN, M., JAKEN, S. and TRITTON, T., Human multidrug resistant KB cells overexpress PKC: involvement in drug resistance. Cancer Comm., 1, 285-292 (1989).
29. SEYNAEVE, C.M., KAZANIETZ, M.G., BLUMBERG, P.M., SAUSVILLE, E.A. and WORLAND, P.J., Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol. Pharmacol., 45, 1207-1214 (1994).
30. STANWELL, C., DLUGOSZ, A.A. and YUSPA, S.H., Staurosporine induces a complete program of terminal differentiation in neoplastic mouse keratinocytes via activation of protein kinase C. Carcinogenesis, 17, 1259-1265 (1996).
31. STANWELL, C., GESCHER, A., BRADSHAW, T.D. and PETTIT, G.R., The role of protein kinase C isoenzymes in growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Int. J. Cancer, 56, 585-592 (1994).
32. TAKAHASHI, I., KOHAYASHI, E., ASANO, K., YOSHIDA, M. and NAKANO, H., UCN-01, a selective inhibitor of protein kinase C from streptomyces. J. Antibiot., 40, 1782-1784 (1987).
33. TAMAOKI, T. and NAKANO, H., Potent and specific inhibitors of protein kinase C of microbial origin. Biotechnology, 8, 732-735 (1990).
34. UTZ, I., HOFER, S., REGENASS, U., HILBE, W., THALER, W., GRÜNICKE, H. and HOFMANN, J., The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance. Int. J. Cancer, 57, 104-110 (1994).
35. WAYS, D.K., KUKOLY, C.A., DEVENTE, Y., HOOKER, Y.L., BRANT, W.O., POSEKANY, J.K., FLETCHER, D.J., COOK, P.P. and PARKER, P.J., MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. clin. Invest., 95, 1906-1915 (1995).
36. WILKINSON, S.E., PARKER, P.J. and NIXON, J.S., Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J., 294, 335-337 (1993).
37. YU, G., AHMAD, S., AQUINO, A., FAIRCHILD, C.R., TREPEL, J.B., OHMO, S., SUZUKI, K., TSURUO, T., COWAN, K.H. and GLAZER, R.I., Transfection with protein kinase C a confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Comm., 3, 181-189 (1991).